Company profile
Erebagen Ltd
ErebaGen Chemistry from Nature
Erebagen Ltd is a UK company with status active founded in 2020 based in South East England.
Latest accounts
Financial period: 1 Apr 2024 to 31 Mar 2025
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Incorporated
InceptionCompany registered at Companies House
Spinout profile
Company description
Natural product pathway bioengineering
Erebagen develops software that uses bioinformatics to discover compounds for pharmaceuticals development.
Our innovation enables us to engineer soil bacteria to produce new bioactive natural product compounds with hit rates 20x-better than synthetic chemicals and create structural variants of bioactive molecules. Our developed platform has applications in several sectors including pharmaceutical and agrochemical - to discover and develop new natural products into new medicines and crop protection compounds.
Project impact
Has identified five early-adopters through ICURe.
2 FTE scientific post currently in the company.
1 FTE scientific post currently in the company.
Public funding
Projects
Enhancing Enzyme Quality and Yield to Unlock Sustainable Biocatalytic Nitration
1 Feb 2026 to 31 Jul 2026
Our project, Novel Biocatalysts for Sustainable Manufacture of Pharmaceuticals, is developing a greener, safer way to produce important pharmaceutical chemicals. Traditional chemical processes for adding nitro groups to molecules require harsh conditions and generate hazardous waste. We are replacing these methods with enzymes called nitrating cytochrome ...
Novel Biocatalysts for Sustainable Manufacture of Pharmaceuticals
1 Mar 2025 to 28 Feb 2027
ErebaGen harnesses chemistry from Nature and its project aims to transform hazardous chemical manufacture through the use of sustainable biological processes. The innovation focus and need is aromatic nitration, a critical chemical step in production of numerous pharmaceutical intermediates. This reaction proceeds rapidly, generates heat, can get out of c...
Genetics to new chemical entities
1 Sep 2021 to 30 Sep 2023
Resistant strains of bacteria, fungi and plants that are not susceptible to modern medicine and crop protection chemicals, pose a serious threat to society. The rise in antibiotic resistant superbugs, drug-resistant cancers and treatment-resistant crop pests are all threatening to have a major impact on our health, quality of life and ultimately the susta...